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A bstract
4-1BB, a transm em brane m olecule, m em ber of the  
tum or necrosis factor receptor superfam ily, is  an  
im portant costim ulatory m olecule in  the im m une 
response, plays a key role in the clonal expansion  
and survival of CD 8+ T  cells. In  th is study, w e in -
vestigated 4-1B B  regulation  of C D 4+ T  cell res -
ponses using 4-1B B  transgenic (TG ) m ice that 
constitutively expressed 4-1B B  on m ature T  cells. 
W e first show ed that C D 4+ T  cells  of 4-1B B  TG  
m ice had m ore sustained proliferative capacity in  
response to  TC R /4-1B B  stim ulation in  vitro  com -
pared to  W T m ice. Secondly, 4-1B B  TG  m ice  
exhibited a m ore elevated contact hypersensitivity  
(C H S) response m ediated  by C D 4+ Th1 cells due  
to  m ore vigorous expansion of and apoptotic  
inhibition of C D 4+ T  cells. F inally, C D 4+ T  cells  of 
4-1B B  TG  m ice had a heightened capacity for T  
cell prim ing. O verall, our results dem onstrate the  
involvem ent of 4-1B B  in  C D 4+ Th1 cell responses  
by regulating the clonal expansion and survival of 
C D 4+ T  cells  as seen in  C D 8+ T  cells.
K eyw o rd s: antigens, CD4; antigens, differentiation; 
cytokines; T lymphocyte; T lymphocyte, hyper-inducer; 
T lymphocyte subsets
In troduction
Optimal immune responses are initiated by the 
engagement of the T-cell receptor (TCR) on T cells 
with MHC/peptide complexes on an antigen (Ag)-pres-
enting cell (APC) and a second costimulatory signal 
(Waldman, 1999). To date, several classes of mole-
cules have been known to function as costimulatory 
molecules, including cell adhesion molecules, CD28/ 
ICOS family, and TNF receptor superfamily members 
(Watts and DeBenedette, 1999). Even though it is not 
clear that all costimulatory molecules are essential for 
T cell responses, it seems that each molecule serves 
different functions with some redundancy and synergy 
to each other. For example, stimulation of CD28 has 
a much larger proliferative effect on CD4+ T cells than 
CD8+ T cells (Watts and DeBenedette, 1999). Like 
CD40 and OX40 (Kopt et al., 1999; Whimire et al., 
1999), CD28 is required for generating antiviral CD4+ 
effector T cells, but is dispensable for CD8+ effector 
T cells (Watts and DeBenedette, 1999). In contrast, 
4-1BB signals are important for the generation of 
antiviral CD8+ effector T cells (DeBeneddette et al., 
1999; Tan et al., 1999; Kwon et al., 2002b). In 
particular, 4-1BB stimulation induces a drastic promo-
tion and prolongation of CD8+ T cell proliferation and 
survival in vivo and in vitro (Takahashi et al., 1999; 
Cooper et al., 2002; Maus et al., 2002). 
  There is accumulating evidence that 4-1BB is 
implicated in immune responses mediated by CD4+ T 
cells, including alloimmune responses (DeBeneddette 
et al., 1999; Blazar et al., 2001; Nozawa et al., 2001) 
and inflammation (Seko et al., 2001; Sun et al., 
2002). Although there is a controversy regarding the 
mechanism by which 4-1BB regulates CD4+ T cell- 
mediated responses, as with CD8+ T cells, signaling 
through 4-1BB appears to promote cell proliferation 
and survival in vitro (Gramaglia et al., 2000; Cannons 
et al., 2001; Wen et al., 2002). However, two in vivo 
observations (Mittler et al., 1999; Sun et al., 2002) 
indicate that there are different mechanisms of 4-1BB 
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costimulation in CD4+ T cells from that in CD8+ T 
cells. Sun et al. (2002) demonstrated that despite an 
early clonal expansion of Ag-specific CD4+ T cells 
after 4-1BB stimulation, the activated CD4+ T cells 
rapidly undergo activation-induced cell death (AICD). 
The difference might be largely due to intrinsic prop-
erty of the two T-cell subsets in terms of their 
proliferative and apoptotic responses to TCR or TCR/ 
4-1BB signals (Fouls et al., 2002; Sun et al., 2002). 
A finding reported by Mittler et al. (1999) suggests 
a novel mechanism by which stimulation of 4-1BB can 
abrogate humoral immune responses against a T-cell- 
dependent Ag through the induction of helper T cell 
anergy, in which process CD8+ T cells do not seem 
to be required. In this case, the mechanism for 4-1BB 
regulation of CD4+ T-cell responses might be via 
4-1BB signal augmentation of the immunosuppres-
sive activity of dendritic cells (DCs), which in turn 
results in suppression of helper T-cell function leading 
to antibody (Ab) production (Mittler et al., 1999).
  In the present study, we assessed CD4+ T cell 
responses using 4-1BB TG mice in vivo and show 
that constitutive expression on CD4+ T cells leads to 
heightened CD4+ T cell-mediated responses. Our data 
indicate that this is due to sustained expansion of 
CD4+ T cells and inhibition of apoptosis of the sub-
sets. Thus, like CD8+ T cells, 4-1BB regulates the 
ability of CD4+ T cells to proceed through cell division 
without extensive apoptosis and is therefore required 
for maximal clonal expansion in the primary CD4+ T 
cell responses.
M ateria ls and M ethods
R eagents
Hyridomas producing anti-4-1BB mAbs (3E1 or 3H3, 
rat IgG2a) were described previously (Shuford et al., 
1997). 3E1 was conjugated with FITC according to 
the standard protocols and 3E1-FITC was used to 
examine cell surface expression of 4-1BB. 3H3 was 
used to stimulate T cells. Anti-CD3 (2C11), anti-CD3- 
FITC, anti-CD4-PE (GK1.5), anti-CD8-PerCP (53-6.7), 
and appropriate isotpe-matched mAbs were from BD 
PharMingen (San Diego, CA). 
4-1B B  transgenic m ice
A full length mouse 4-1BB DNA containing BamHI 
sites at both 5' and 3' ends was generated by PCR, 
using a 4-1BB cDNA as a template, and inserted into 
the BamHI sites of the plasmid p1017 which contains 
the lck proximal promoter, the human growth hormone 
gene genomic sequence and a poly (A)+ site (Figure 
1A; Chaffin et al., 1990; Shimizu et al., 2001). A 
fragment containing lck promoter/4-1BB/human growth 
hormone/poly (A)+ site was excised by NotI and used 
for subsequent microinjection. 4-1BB transgenic 
founder mice were generated by injecting the 
fragment into FvB eggs. Southern blot analysis of tail 
DNA was used to screen for transgenic animals. One 
line generated from founders expressed high levels 
of 4-1BB mRNA and protein (Figure 1A and B). This 
line was backcrossed to the C57BL/6 strain more 
than three generations. 
Proliferation  assay
1×105 cells/well were cultured in 96-well plates (Co-
star, Cornimg, NY) in triplicate and cell division was 
assessed by the addition of 1 µCi [3H] thymidine (ICN 
Biomedicals, Irvine, CA) to 0.2 ml cultures for the last 
18 h of culture. Cells used for the proliferation assay 
were thymocytes, total splenocytes or purified CD4+ 
T cells or CD8+ T cells. CD4+ or CD8+ T cells were 
purified using anti-CD4 or anti-CD8-conjugated mag-
netic beads (MACS) from Mitenyi Biotech (Auburn, CA). 
Purity was confirmed to be over 90% by FACScan flow 
cytometry.
C ontact hypersensitivity  (C H S) responses
For 1-fluoro-2,4-dinitrobenzene (DNFB)-induced CHS, 
wild type (WT) and transgenic (TG) mice were 
sensitized epicutaneously with 0.1% DNFB in ace-
tone:olive oil (4:1) on days 0 and 1 and then chal-
lenged epicutaneously on day 5 with 0.25% DNFB. 
Ear thickness was measured with a low pressure 
spring-loaded engineer's micrometer (Mitutoyo, Tokyo, 
Japan) before the allergen challenge (0 h) and 24 and 
48 h after the allergen challenge. In some cases, 
lymphocytes were isolated from the draiming lymph 
node (DLNs) and stainded with anti-CD4-PE or anti- 
CD8-PerCP plus annexin V-FITC. The stained cells 
were analyzed on FACScan flow cytometry.
In  vivo  T  cell prim ing and recall responses
stim ulated  w ith  K LH
WT and TG mice were immunized with 50 µg of KLH 
together with CFA in a total volume of 50 µl into each 
hind footpad. On day 9 after immunization, CD4+ T 
cells were purified from the DLNs. 5×104 of the 
purified CD4+ T cells were added into each well of 
a 96-well plate and stimulated with the indicated 
concentration of KLH in the presence of 2.5×105 
APCs for 3 days. Purity was confirmed to be ＞90%. 
The APCs used were isolated from WT spleens and 
irradiated (2000 rad). Proliferation was assessed as 
described above.
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In  vivo  production  of K LH -specific  A b
Fifty µg of KLH was used to immunize WT and TG 
mice as describe above. For the primary Ab determin-
ation, serum was collected on day 7 for IgM and day 
14 for the IgG3 to examine the concentration of anti- 
KLH-specific Abs. 
A ssay for anti-K LH -specific  A b production
Each well of an ELISA microplate was coated with 
10 µg/ml of KLH in carbonate buffer (pH 9.0) by 
overnight incubation at 4oC. Plates were washed and 
subsequently blocked with 1% BSA in PBS for 1 h 
at 37oC. Sera from WT or TG mice, diluted in PBS 
(from 1:10 to 1:10,000), were added to the wells and 
incubated for 1 h at room temperature. The plates 
were then washed, and bound Abs were diluted by 
incubation with goat anti-mouse IgM or IgG3 conju-
gated with horseradish peroxidase (Southern Biotech-
nology Associates, Birmingham, AL). After an addi-
tional 1-h incubation, color reactions were performed 
using 1-step slow TMB-ELISA substrate (Pierce, Rock-
ford, IL). The reaction was stopped by 2 M H2SO4, 
and the OD readings at 405 nm were evaluated.
R esu lts
G eneration of 4-1B B  TG  m ice in  the  
T  cell lineage
4-1BB is not expressed on resting T cells and is 
upregulated by activation (Vinay and Kwon, 1999; 
Kwon et al., 2000; Kwon et al., 2002a; Kwon et al., 
2003). To investigate the role of 4-1BB in T cells in 
vivo, we generated TG mice that constitutively 
express the 4-1BB protein under the control of the 
proximal lck promoter (Figure 1A), which gives rise 
to a T cell lineage-specific expression of 4-1BB 
(Chaffin et al., 1990; Shimizu et al., 2001). By South-
ern blot using a full-length 4-1BB cDNA probe, two 
transgene-positive founders were identified and bred 
(Figure 1B). Northern blot analysis showed that one 
line expressed abundant 4-1BB mRNA in thymus, and 
less in lymph nodes and spleen (Figure 1C). Other 
organs did not express 4-1BB. Consistent with the 
Northern blot result, a similar expression pattern of 
the 4-1BB protein were found in thymus, lymph node, 
and spleen (Figure 1D). Using FACS, high levels of 
4-1BB expression were also observed on thymocytes 
of TG mice. Approximately 90% of CD4+ or CD8+ 
thymocytes expressed 4-1BB, indicating that 4-1BB 
began to be expressed from the double positive 
(CD4+CD8+) stage of thymocyte development (Figure 
2A). As expected, 4-1BB was expressed on essen-
tially all mature CD4+ and CD8+ T cells of peripheral 
lymphoid tissues, including spleen, lymph node, and 
peripheral blood (Figure 1B-D).
  4-1BB TG mice were normal in gross appearance, 
size, body weight, and reproductive activities. There 
was no abnormality in the development of lymphoid 
organs in TG mice: The lymphoid organs contained 
similar profiles of CD4+ T cells, CD8+ T cells, B cells, 
and macrophages to those of littermate control (WT) 
mice (data not shown). The TG mice also did not 
display splenomegaly and B cell depletion with aging 
as seen in 4-1BB ligand (4-1BBL) TG mice which 
were engineered to overexpress 4-1BBL on APCs 
(Zhu et al., 2001). However, the thymocytes of TG 
mice had defects in the proliferative response to TCR 
or TCR/4-1BB stimulation and they underwent a
F ig u re  1 . Construct of 4-1BB transgene and its expression. (A) A 
schematic map of the 4-1BB transgene construct. The cDNA of murine
4-1BB was inserted into the p1071 plasmid between the lck proximal
promoter and human growth hormone genomic sequence. NotI 
restriction digest was then used to isolate the transgene cassette from
the plasmid. (B) Southern blot of isolated mouse genomic DNA. 
Nontransgenic (WT) and two lines of transgenic (TG) mice were 
compared. Southern analysis of BamHI-digested mouse genomic DNA
was performed using radiolabeled 4-1BB cDNA as a probe. (C) 
Northern blot analysis of various organs from TG (otherwise indicated).
Fifteen µ g of total RNA was used for hybridization. 1, brain; 2, salivary
gland; 3, heart; 4, thymus; 5, thymus (WT); 6, lung; 7, liver; 8, 
pancreas; 9, spleen; 10, kidney; 11, lymph node; 12, lymph node 
(WT). (D) Immunoprecipitation-Western blot analysis of thymus, lymph
node, and spleen. A single cell suspension was prepared from TG
thymus, lymph node, or spleen, and 1×106 cells/ml were biotinylated
according to the manufacturer (Pierce, Rockford, IL). Cell lysate was
then immunoprecipitated using 3 µ g of anti-4-1BB (1AH2) or isotype
IgG. Western blotting was performed with streptavidin coupled with 
alkaline phosphatase.
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significantly higher percentage of apoptosis during in 
vitro culture for 24 h compared to WT mice (manu-
script in preparation).
A  heightened and sustained C D 4+ T  cell
pro liferative response of 4-1B B  TG  vs W T m ice
To directly evaluate the role of constitutively expres-
sed 4-1BB in regulating the response of T cells, total 
F ig u re  2 . 4-1BB expression on T cells of 4-1BB TG mice. T cells were isolated from thymus (A), spleen (B), lymph nodes (C), or peripheral
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splenocytes of WT and TG mice were used to test 
their ability to respond to an optimal dose of anti-CD3 
(for TCR stimulation) or anti-CD3/4-1BB. As shown in 
Figure 3A, TG splenocytes exhibited a significantly 
higher proliferation in response to TCR or TCR/4-1BB 
stimulation than did WT splenocyted. When we 
examined the proliferative response of purified CD4+ 
T cells to TCR or TCR/4-1BB stimulation on a daily 
base, CD4+ T cells of TG vs WT mice showed dif-
ferent proliferation patterns (Figure 3B and C). WT 
CD4+ T cells had a maximal level of proliferative re-
sponses to TCR or TCR/4-1BB stimulation on day 2 
and their proliferation declined thereafter (Figure 3B). 
In contrast, TG CD4+ T cells maintained their pro-
liferative capcacity in response to TCR stimulation 
after day 2 (Figure 3C). When simultaneously stim-
ulated by anti-CD3 and anti-4-1BB, the proliferative 
response of TG CD4+ T cells kept on increasing until 
day 4. A similar pattern of proliferative responses of 
TG CD8+ T cells was observed as seen in CD4+ T 
cells. These data suggest that enforced overexpres-
sion of 4-1BB in T cells heightens and sustains the 
proliferative capacity of T cells. 
H eightened contact hypersensitivity  responses  
in  4-1B B  TG  vs W T m ice
Contact hypersensitivity (CHS) is believed to be medi-
ated by CD4+ T cells. CHS responses in TG was 
examined vs WT mice. For this study, the Th1 pre-
dominant allergen dinitro-flourobenzene (DNFB) was 
used as the allergen (Simon et al., 1994). As shown 
in Figure 4A, 4-1BB TG mice exhibited significantly 
increased ear swelling when measured at 24 h and 
48 h after DNFB challenge. Since allergen-specific 
CD4+ T cells are expanded after the allergen chal-
lenge and their pool determines the extent of CHS 
responses, we examined T cell population of DLNs. 
Reflecting the CHS result, the DLNs of TG mice 
contained a significantly higher percentage of CD4+ 
T cells than did those of WT mice (Figure 4B). In 
contrast, a similar percentage of CD8+ T cells existed 
in the DLNs of both groups of mice (not shown), 










































F ig u re  3 . A heightened and sustained CD4+ T cell proliferative 
response of 4-1BB TG vs littermate control (WT) mice. (A) Spleno-
cytes of 4-1BB TG and WT mice were isolated and cultured for 
48 h in the presence of 1 µ g/ml of anti-CD3 mAb or anti-CD3 
plus 5 µ g/ml of anti 4-1BB mAbs and pulsed with 1 µ Ci 
[3H]thymidine for the last 18 h  (B and C). CD4+ T cells were 
purified from spleens and lymph nodes of W T (B) and 4-1BB TG 
(C) mice. Proliferation was determined as described above. Data 
are presented as mean±SD from n = 5 m ice each group. 
Experiments was done two times and similar results were obtained.
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CD4+ T cells. Interestingly, we consistently observed 
a significantly lower percentage of Annexin V-positive 
CD4+ T cells in the DLNs of TG mice (Figure 4C). 
There was a small population of CD8+ T cells 
undergoing apoptosis in the DLNs of both groups of 
mice, which might correspond to apoptotic CD8+ T 
cells for maintaining homeostasis (data not shown). 
Taken together, these data suggest that constitutive 
expression of 4-1BB on T cells greatly promotes 
expansion and survival of Ag-specific CD4+ T cells. 
Enhancem ent of T  cell prim ing and A g-specific
A b production  in  4-1B B  TG  m ice
To further examine the in vivo effect of constitutively- 
expressed 4-1BB on Ag-specific T cell activation, TG 
or WT mice was immunized with keyhole limpet 
hemocyanin (KLH) and tested their in vitro T cell 
recall proliferative response. Recall proliferative as-
says were performed using purified CD4+ T cells from 
immunized mice and APCs derived from unimmunized 
WT mice. A significantly enhanced response was 
observed in TG mice, and the Ag dose-response 
curve was shifted by several orders of magnitude 
(Figure 5A). These results suggest that constitutive 
expression of 4-1BB on T cells greatly contributes to 
enhancement of Ag-specific T cell priming.
  The role of 4-1BB was next investigated during the 
course of primary humoral immune responses against 
KLH, a well-known T cell-dependent Ag. Sera from 
TG mice exhibited no difference from those from WT 
mice in KLH-specific IgM Ab production (Figure 5B). 
This was expected because IgM is known to be T 
cell-independent. In contrast, production of higher lev-
els of T cell-dependent IgG3 Abs was observed in 
TG vs WT mice. Increased production of IFN-γ in TG 
mice may explain the increase in IgG3 because IFN-γ 
is known to drive IgG3 switching (Finkelman et al., 
1998).
D iscussion
In this study, an insight into 4-1BB regulation of CD4+ 
T cell responses was explored by comparing CD4+ 










































F ig u re  4 . A heightened contact hypersensitivity response of 
4-1BB TG vs. littermate control (WT) mice due to higher 
expansion and inhibition of apoptosis of CD4+ T cells. (A) For 
DNFB-induced CHS, W T and 4-1BB TG mice were sensitized 
with 0.5% DNFB on days 4 and 5 prior to challenge with 0.25% 
DNFB on the ear. Ear swelling was measured before DNFB 
challenge on day 5, and 24 and 48 h later. Data are presented 
as mean±SD (five mice per group). **Statistically different 
between W T and 4-1BB TG m ice at the indicated time point 
(P ＜0.01). (B and C) Forty-eight hours after CHS induction by 
DNFB as described above, cells were isolated from the DLNs, 
and stained with anti-CD4-PE mAb plus annexin V-FITC. Shown 
are the percentage of CD4+ T cells (B) and the percentage of 
apoptotic CD4+ T cells among total CD4+ T cells. Data are 
presented as mean±SD. *Statistically different between W T and 
4-1BB TG mice (P ＜0.05). Data shown are representative of 
three experiments.
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in 4-1BB TG mice that were engineered to consti-
tutively express 4-1BB on mature T cells. Recently, 
the costimulatory mechanism regulated by 4-1BB has 
been revealed in CD8+ T cells. Remarkable growth 
and survival of CD8+ T cells can be achieved by TCR/ 
CD28/4-1BB stimulation compared with TCR/CD28 
stimulation (Maus et al., 2002). Since 4-1BB expres-
sion is induced by TCR or TCR/CD28 signals, these 
findings suggest the need for 4-1BB signals to sustain 
the growth and survival of CD8+ T cells (Watts and 
DeBenedette, 1999). This idea is also supported by 
the observation that naive CD8+ T cells initially acti-
vated via TCR/CD28 signals become refractory to re-
peated TCR/CD28 stimulation (Kim et al., 1998). The 
promotion and prolongation of CD8+ T cell prolifera-
tion and survival by 4-1BB costimulation appears to 
be mediated, at least in part, through increased pro-
duction of IL-2 and expression of Bcl-xL (Lee et al., 
2002; Maus et al., 2002). These in vitro results were 
confirmed by in vivo findings indicating that 4-1BB 
costimulatory signals play a crucial role in the 
generation of effector and memory cytotoxic T cells 
(CTLs) by increasing the number of CTLs cells 
(DeBeneddette et al., 1999; Tan et al., 1999; Cooper 
et al., 2000; Bertram et al., 2002; Kwon et al., 2002b).
  Two in vitro observations have provided evidence 
that similarly to CD8+ T cells, 4-1BB signals can sup-
port cell proliferation and survival of CD4+ T cells 
(Cannons et al., 2001; Wen et al., 2002). In this 
study, the sustained proliferative response of TG 
CD4+ T cells was demonstrated after in vitro TCR/ 
4-1BB stimulation, which was not seen in that of WT 
CD4+ T cells. These results indicate that constitutive 
expression on 4-1BB on CD4+ T cells might make a 
critical contribution to maintaining the proliferative ca-
pacity. These data also indicate that the sustained 
proliferative response of TG CD4+ T cells could take 
place without CD28 signals that are required for the 
induction of 4-1BB expression on WT T cells together 
with TCR signals. Even though the exact number of 
allergen-specific CD4+ T cells in CHS responses was 
not measured, the DLNs of TG mice showed exis-
tence of a significantly higher percentage of CD4+ T 
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F ig u re  5 . An elevated recall proliferative response and Ab 
production to KLH. (A) 4-1BB TG and littermate control (W T) 
mice were immunized with KLH in the hind footpads. Nine 
days after immunization, CD4+ T cells were purified from the 
DLNs and were restimulated with various concentration of KLH 
in the presence of APCs. After culturing for 3 d, [3H]thymidine 
uptake was measured. Data shown are expressed as mean±
SD and representative of two experiments (n = 5 m ice each 
group). (B and C) Primary Ab responses to KLH in 4-1BB TG 
and WT mice were evaluated. After KLH immunization, serum 
was collected on day 7 for IgM and day 14 for the IgG3 to 
examine the concentration of KLH-specific Abs. The con-
centration of KLH-specific IgM (B) and IgG3 (C) was deter-
mined by measuring the OD at 495 nm, of triplicates for indi-
vidual mice, using serially-diluted serum samples. Data shown 
are expressed as mean±SD of n = 5 mice each group.
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the poulation size of the clonally expanded allergen- 
specific CD4+ T cells. This idea was further supported 
by two observations. One is that the proliferative 
response of KLH-specific CD4+ T cells was greater 
in TG mice than was in WT mice. Another is that 
a similar percentage of CD8+ T cells presumably 
representing those that were not specific for the 
allergen was contained in the DLNs of TG and WT 
mice after the allergen challenge. Moreover, CD4+ T 
cells of TG mice exhibited a remarkedly reduced 
apoptosis after the allergen challenge. Taken togeth-
er, these in vivo data are consistent with the in vitro 
results showing that 4-1BB signals induce progression 
of cell division and sustaining survival of CD4+ T cells.
  Analysis of TG mice demonstrated enhanced IgG3 
production to KLH compared with WT mice. Since 
KLH is known to be a T cell-dependent Ag on Ab 
production, the enhanced Ab responses observed 
may be due to enhanced T cell priming. As indicated 
in CHS responses, 4-1BB signals play a critical role 
in the induction of inflammatory CD4+ Th1 responses. 
Similarly, 4-1BB signals may evoke CD4+ Th1 IFN-γ 
expression and switch B cells to make IFN-γ-depen-
dent Abs such as IgG2a and IgG3. This idea can be 
supported by the observations that 4-1BB-deficient 
mice had reduced production of IgG2a and IgG3 to 
KLH than did WT mice (Kwon et al., 2002b) and also 
by the observations that blockade of the 4-1BB cos-
timulatory signals resulted in enhanced Th2-depen-
dent IgE and anti-double standed DNA (dsDNA) IgG1 
autoantibody production possibly via increased pro-
duction of IL-4 and decreased production of IFN-γ in 
chronic graft-versus-host disease (GVHD) (Nozawa et 
al., 2001). Reversely, stimulation of 4-1BB totally 
abrogates Th2-dependent Ab production (Kim J and 
Kwon B, unpublished data). These data together high-
light the involvement of 4-1BB costimulatory signals 
in CD4+ Th1-mediated immune responses. However, 
we could not exclude the possibility that 4-1BB is 
involved in CD4+ Th2 responses. Currently, studies 
are under way to reveal this aspect of 4-1BB func-
tion. 
  In summary, we have shown that 4-1BB represents 
an important costimulatory molecule in the CD4+ Th1 
T cell response. The primary mechanism of action 
appears to be to regulate proliferation and cell sur-
vival. Thus overall 4-1BB acts to determine the num-
ber of CD4+ T cells that are generated in the primary 
immune responses. Further studies will be needed to 
define the involvement of 4-1BB in Th1 vs Th2 re-
sponses.
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